Bank Pictet & Cie (Europe)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.6M | Buy |
717,973
+76,739
| +12% | +$4.17M | 0.6% | 37 |
|
|
2026
Q1 | $40.2M | Buy |
641,234
+486,715
| +315% | +$38.9M | 0.86% | 34 |
|
|
2025
Q4 | $14.7M | Sell |
154,519
-3,417
| -2% | -$335K | 0.29% | 64 |
|
|
2025
Q3 | $15.4M | Sell |
157,936
-6,718
| -4% | -$696K | 0.31% | 60 |
|
|
2025
Q2 | $17.7M | Buy |
164,654
+70,753
| +75% | +$7.16M | 0.38% | 57 |
|
|
2025
Q1 | $9.47M | Buy |
93,901
+20,805
| +28% | +$2.09M | 0.23% | 66 |
|
|
2024
Q4 | $6.53M | Buy |
73,096
+21,173
| +41% | +$1.86M | 0.14% | 78 |
|
|
2024
Q3 | $4.35M | Sell |
51,923
-27,416
| -35% | -$2.16M | 0.1% | 78 |
|
|
2024
Q2 | $6.11M | Buy |
79,339
+23,486
| +42% | +$1.72M | 0.15% | 72 |
|
|
2024
Q1 | $3.83M | Sell |
55,853
-1,846
| -3% | -$119K | 0.1% | 82 |
|
|
2023
Q4 | $3.34M | Sell |
57,699
-95,504
| -62% | -$5.1M | 0.1% | 96 |
|
|
2023
Q3 | $8.09M | Buy |
153,203
+131,853
| +618% | +$6.92M | 0.28% | 65 |
|
|
2023
Q2 | $1.15M | Buy |
21,350
+2,072
| +11% | +$108K | 0.04% | 132 |
|
|
2023
Q1 | $964K | Buy |
19,278
+563
| +3% | +$26.5K | 0.04% | 108 |
|
|
2022
Q4 | $866K | Buy |
18,715
+200
| +1% | +$8.66K | 0.04% | 106 |
|
|
2022
Q3 | $717K | Sell |
18,515
-8,734
| -32% | -$350K | 0.04% | 111 |
|
|
2022
Q2 | $1.02M | Sell |
27,249
-10,545
| -28% | -$429K | 0.05% | 98 |
|
|
2022
Q1 | $1.67M | Sell |
37,794
-543
| -1% | -$23.5K | 0.06% | 91 |
|
|
2021
Q4 | $1.63M | Sell |
38,337
-77,100
| -67% | -$3.24M | 0.06% | 92 |
|
|
2021
Q3 | $5.01M | Sell |
115,437
-239,695
| -67% | -$10.6M | 0.19% | 69 |
|
|
2021
Q2 | $15.2M | Sell |
355,132
-310,329
| -47% | -$13.1M | 0.53% | 43 |
|
|
2021
Q1 | $25.7M | Buy |
665,461
+31,473
| +5% | +$1.19M | 1.03% | 31 |
|
|
2020
Q4 | $22.8M | Buy |
633,988
+620,800
| +4,707% | +$22.4M | 1.12% | 32 |
|
|
2020
Q3 | $504K | Sell |
13,188
-6,730
| -34% | -$259K | 0.03% | 96 |
|
|
2020
Q2 | $699K | Buy |
19,918
+2,987
| +18% | +$108K | 0.05% | 82 |
|
|
2020
Q1 | $552K | Buy |
16,931
+164
| +1% | +$6.41K | 0.05% | 87 |
|
|
2019
Q4 | $758K | Sell |
16,767
-3,010
| -15% | -$126K | 0.11% | 85 |
|
|
2019
Q3 | $805K | Sell |
19,777
-370
| -2% | -$15.7K | 0.14% | 80 |
|
|
2019
Q2 | $866K | Buy |
20,147
+14,177
| +237% | +$545K | 0.15% | 74 |
|
|
2019
Q1 | $229K | Sell |
5,970
-9,370
| -61% | -$358K | 0.04% | 144 |
|
|
2018
Q4 | $542K | Buy |
15,340
+3,170
| +26% | +$115K | 0.11% | 74 |
|
|
2018
Q3 | $469K | Buy |
+12,170
| New | +$425K | 0.07% | 131 |
|
Other funds holding BSX
Bank Pictet & Cie (Europe)'s BSX Position: Q2 2026 in Review
Bank Pictet & Cie (Europe) increased its Boston Scientific (BSX) stake by 12% in Q2 2026, buying an estimated $4.17M and bringing the position to 717,973 shares worth $30.6M. The position accounts for 0.6% of the portfolio, ranked #37.
Bank Pictet & Cie (Europe) first reported a position in BSX in Q3 2018 and has held it in 32 quarters since. The position peaked at $40.2M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Bank Pictet & Cie (Europe) held 717,973 shares of Boston Scientific worth $30.6M as of Q2 2026.
- Bank Pictet & Cie (Europe) bought 76,739 Boston Scientific shares in Q2 2026, an estimated $4.17M.
- Boston Scientific made up 0.6% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #37 holding.
- Bank Pictet & Cie (Europe) first reported a position in Boston Scientific in Q3 2018 and has held it in 32 quarters since.
- Bank Pictet & Cie (Europe)'s Boston Scientific position peaked at $40.2M in Q1 2026.
- 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.